Lexpos News

As we move into the warmer months, pharmacy teams may start to see people presenting with tick bites and potentially symptoms of Lyme disease. While tick bites/Lyme disease is not treatable under the Pharmacy First clinical pathway for infected insect bites, with patients needing to be signposted onwards, patients may present with a tick bite [...]

The post Pharmacy First: Recognition of tick bites and the symptoms of Lyme disease appeared first on Community Pharmacy England.

NHS England has announced, that it has opened applications for pharmacists for funded independent prescribing courses. Courses are available up to March 2026, with several universities offering multiple dates for cohort intakes. Start dates will depend on the university provider. Community pharmacists (including locum pharmacists) considering an application, will need to demonstrate (as a minimum): [...]

The post NHS England funded independent prescribing courses 2025/26 appeared first on Community Pharmacy England.

Ahead of negotiations on the Community Pharmacy Contractual Framework (CPCF) for 2026/27 and beyond, Community Pharmacy England is keen to discuss pressing issues and the future of the sector with pharmacy owners and LPCs. All pharmacy owners and their representatives are therefore invited to attend our regional ‘Future of Pharmacy’ workshops to discuss what next [...]

The post 2025 Community Pharmacy England Workshops appeared first on Community Pharmacy England.

Community Pharmacy England would like to remind pharmacy owners of the requirement to submit their FP34C declaration using the Manage Your Service (MYS) portal and to dispatch any prescription bundles to the relevant pricing division at the NHS Business Services Authority (NHSBSA) no later than the 5th day of the month following that in which [...]

The post Reminder: Submit your FP34C declaration and prescription bundles on time appeared first on Community Pharmacy England.

Following representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status from 1 June 2025. Generic drug name (dm+d descriptor) Brand and/or Manufacturer Pack size Special container Carmellose 1% eye drops 0.4ml unit dose preservative free Celluvisc® 1% eye drops [...]

The post 4 products re-classified as special containers from June 2025 appeared first on Community Pharmacy England.